Tryptophan-Tyrosine Dipeptide, the Core Sequence of β-Lactolin, Improves Memory by Modulating the Dopamine System.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
06 Feb 2019
Historique:
received: 10 01 2019
revised: 02 02 2019
accepted: 03 02 2019
entrez: 10 2 2019
pubmed: 10 2 2019
medline: 30 3 2019
Statut: epublish

Résumé

Tryptophan-tyrosine (WY)-related peptides including the β-lactopeptide of the glycine-threonine-tryptophan-tyrosine peptide, β-lactolin, improve spatial memory. However, whether and how the WY dipeptide as the core sequence in WY-related peptides improves memory functions has not been investigated. This study assessed the pharmacological effects of the WY dipeptide on memory impairment to elucidate the mechanisms. Here, we showed that oral administration of dipeptides of WY, tryptophan-methionine (WM), tryptophan-valine, tryptophan-leucine, and tryptophan-phenylalanine improved spontaneous alternation of the Y-maze test in scopolamine-induced amnesic mice. In contrast, tyrosine-tryptophan, methionine-tryptophan, tryptophan, tyrosine, and methionine had no effect. These results indicated that the conformation of dipeptides with N-terminal tryptophan is required for their memory improving effects. WY dipeptide inhibited the monoamine oxidase B activity in vitro and increased dopamine levels in the hippocampus and frontal cortex, whereas tryptophan did not cause these effects. In addition, the treatment with SCH-23390, a dopamine D1-like receptor antagonist, and the knockdown of the hippocampal dopamine D1 receptor partially attenuated the memory improvement induced by the WY dipeptide. Importantly, WY dipeptide improved the spontaneous alternations of the Y-maze test in aged mice. These results suggest that the WY dipeptide restores memory impairments by augmenting dopaminergic activity. The development of supplements rich in these peptides might help to prevent age-related cognitive decline.

Identifiants

pubmed: 30736353
pii: nu11020348
doi: 10.3390/nu11020348
pmc: PMC6412195
pii:
doi:

Substances chimiques

Dipeptides 0
Tyrosine 42HK56048U
Tryptophan 8DUH1N11BX
Scopolamine DL48G20X8X
Dopamine VTD58H1Z2X

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Neurobiol Learn Mem. 2010 Feb;93(2):291-301
pubmed: 19931627
Dement Geriatr Cogn Disord. 2010;30(4):352-61
pubmed: 20938179
Biomol Concepts. 2011 Oct 1;2(5):365-377
pubmed: 22022344
Neurobiol Learn Mem. 2012 Feb;97(2):271-5
pubmed: 22266268
Nat Neurosci. 2013 May;16(5):648-53
pubmed: 23525044
Am J Clin Nutr. 2013 May;97(5):1076-82
pubmed: 23553168
Int J Neuropsychopharmacol. 2013 Oct;16(9):2041-51
pubmed: 23672849
Nat Commun. 2013;4:2502
pubmed: 24060756
Behav Brain Res. 2014 Mar 15;261:249-57
pubmed: 24333574
Mol Med Rep. 2014 May;9(5):1533-41
pubmed: 24626484
J Am Geriatr Soc. 2014 Jul;62(7):1224-30
pubmed: 24916840
Neurobiol Aging. 2015 Mar;36(3):1529-42
pubmed: 25499799
PLoS One. 2015 Mar 11;10(3):e0118512
pubmed: 25760987
J Enzyme Inhib Med Chem. 2016;31(3):389-97
pubmed: 25798687
Clin Nutr. 2016 Apr;35(2):507-513
pubmed: 25921203
Cell Death Dis. 2015 Nov 05;6:e1965
pubmed: 26539912
Neurobiol Aging. 2016 Apr;40:98-102
pubmed: 26973108
Neurochem Int. 2016 Oct;99:147-157
pubmed: 27374845
Nature. 2016 Sep 15;537(7620):357-362
pubmed: 27602521
Trends Neurosci. 2017 Jul;40(7):383-384
pubmed: 28511793
J Pharmacol Exp Ther. 2017 Sep;362(3):413-423
pubmed: 28642233
Mol Psychiatry. 2018 Aug;23(8):1717-1730
pubmed: 28924188
Int J Mol Sci. 2018 Jun 30;19(7):null
pubmed: 29966358
Nutrients. 2018 Jul 13;10(7):null
pubmed: 30011836
Neurobiol Aging. 2018 Dec;72:23-31
pubmed: 30176402
FASEB J. 2019 Apr;33(4):4987-4995
pubmed: 30601670

Auteurs

Yasuhisa Ano (Y)

Research Laboratories for Health Science & Food Technologies, Kirin Company Ltd, Kanazawa-ku, Yokohama-shi, Kanagawa 236-0004, Japan. Yasuhisa_Ano@kirin.co.jp.

Tatsuhiro Ayabe (T)

Research Laboratories for Health Science & Food Technologies, Kirin Company Ltd, Kanazawa-ku, Yokohama-shi, Kanagawa 236-0004, Japan. Tatsuhiro_Ayabe@kirin.co.jp.

Rena Ohya (R)

Research Laboratories for Health Science & Food Technologies, Kirin Company Ltd, Kanazawa-ku, Yokohama-shi, Kanagawa 236-0004, Japan. Rena_Ohya@kirin.co.jp.

Keiji Kondo (K)

Research Laboratories for Health Science & Food Technologies, Kirin Company Ltd, Kanazawa-ku, Yokohama-shi, Kanagawa 236-0004, Japan. kondok@kirin.co.jp.

Shiho Kitaoka (S)

Division of Pharmacology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan. skitaoka@med.kobe-u.ac.jp.
AMED-CREST, Chiyoda-ku 100-0004, Tokyo, Japan. skitaoka@med.kobe-u.ac.jp.

Tomoyuki Furuyashiki (T)

Division of Pharmacology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan. tfuruya@med.kobe-u.ac.jp.
AMED-CREST, Chiyoda-ku 100-0004, Tokyo, Japan. tfuruya@med.kobe-u.ac.jp.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH